Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Optimizing Medication and Vaccination Adherence in Rheumatoid Arthritis in the COVID-19 Era: Development of a Patient-Centered Intervention

EF 2022-23

Résumé
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, pain, swelling and stiffness. Potent immunosuppressants are essential to control inflammation, slow joint damage, and improve symptoms and function. Yet, many people with RA do not take their medications as prescribed. Adherence to treatment is related to an individual's beliefs about the necessity of taking medicines and concerns about taking them. We showed that among newly diagnosed adults with RA, half were not convinced about the importance of taking RA medicines and were highly concerned about long-term safety. Taking immunosuppressants places people with RA at a higher risk of getting the flu and potentially COVID-19. While flu shot is the best way to protect against the flu, less than half of Canadians with RA report getting an annual flu shot. We have recently explored vaccination and medication beliefs and found that people with RA who had the flu shot were also more likely to believe that taking RA medication was important, and were relatively less concerned about the safety of the RA medicines (as compared with people who were unvaccinated). The goal of this project is to improve medication and flu vaccination adherence in people with RA by encouraging rheumatologists to talk with their patients about their medication beliefs and fears as part of shared decision making and treatment monitoring. We will conduct focus groups with patients to explore perceptions about medications and flu vaccinations. A survey will be conducted to examine how rheumatologists address medication and flu vaccination concerns. Results will be used to develop an intervention to guide patient-physician conversations about medication and vaccination beliefs and concerns. A pilot test in arthritis centers will be used to gather information about acceptability, feasibility of outcomes (adherence, patient & physician satisfaction, quality of life) and to help us plan a larger study.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
475809
Name
Ta Viviane
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Optimizing Medication and Vaccination Adherence in Rheumatoid Arthritis in the COVID-19 Era: Development of a Patient-Centered Intervention
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Medication Adherence; Mixed Methods; Patient Perceptions; Patient-Physician Communication; Patients Oriented Research; Physician Perceptions; Rheumatoid Arthritis
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, pain, swelling and stiffness. Potent immunosuppressants are essential to control inflammation, slow joint damage, and improve symptoms and function. Yet, many people with RA do not take their medications as prescribed. Adherence to treatment is related to an individual's beliefs about the necessity of taking medicines and concerns about taking them. We showed that among newly diagnosed adults with RA, half were not convinced about the importance of taking RA medicines and were highly concerned about long-term safety. Taking immunosuppressants places people with RA at a higher risk of getting the flu and potentially COVID-19. While flu shot is the best way to protect against the flu, less than half of Canadians with RA report getting an annual flu shot. We have recently explored vaccination and medication beliefs and found that people with RA who had the flu shot were also more likely to believe that taking RA medication was important, and were relatively less concerned about the safety of the RA medicines (as compared with people who were unvaccinated). The goal of this project is to improve medication and flu vaccination adherence in people with RA by encouraging rheumatologists to talk with their patients about their medication beliefs and fears as part of shared decision making and treatment monitoring. We will conduct focus groups with patients to explore perceptions about medications and flu vaccinations. A survey will be conducted to examine how rheumatologists address medication and flu vaccination concerns. Results will be used to develop an intervention to guide patient-physician conversations about medication and vaccination beliefs and concerns. A pilot test in arthritis centers will be used to gather information about acceptability, feasibility of outcomes (adherence, patient & physician satisfaction, quality of life) and to help us plan a larger study.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ta, Viviane
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~